Luteolin exerts dual anti-NPC effects: G1-phase cell cycle arrest via Akt/GSK-3β/cyclin D1 axis (37) and EBV lytic gene suppression (30). This evidence concerns the gene GSK3B and nasopharyngeal carcinoma.